A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma (EVERMORE)

Sponsor and Collaborators
Novartis Pharmaceuticals

Contact
Novartis Pharmaceuticals
+1 800-340-6843

Study Director
Novartis Pharmaceuticals

ClinicalTrials.gov Identifier
NCT01206764